Article
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
The New England journal of medicine - 29 Jan 2009
Mullighan Charles G, Su Xiaoping, Zhang Jinghui, Radtke Ina, Phillips Letha A A, Miller Christopher B, Ma Jing, Liu Wei, Cheng Cheng, Schulman Brenda A, Harvey Richard C, Chen I-Ming, Clifford Robert J, Carroll William L, Reaman Gregory, Bowman W Paul, Devidas Meenakshi, Gerhard Daniela S, Yang Wenjian, Relling Mary V, Shurtleff Sheila A, Campana Dario, Borowitz Michael J, Pui Ching-Hon, Smith Malcolm, Hunger Stephen P, Willman Cheryl L, Downing James R
Abstract excerpt
BACKGROUND: Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined. METHODS: We studied a cohort of 221 children with high-risk B-cell-progenitor ALL with the use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.